Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in RZLT — Rezolute, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to RZLT Full portfolio

Position in RZLT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,762,657
+$1,815,586 QoQ
Shares Held
723,588
+13.3% QoQ
Ownership
0.751%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 144 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. RZLT ranks #160 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in RZLT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,762,657 723,588
2026-03-31 $1,947,071 638,384
2025-12-31 $1,569,772 665,158
2025-09-30 $6,130,106 652,139
2025-06-30 $907,971 203,581
2025-03-31 $65,995 22,757
2024-12-31 $111,509 22,757
2024-09-30 $66,721 13,757
2024-06-30 $59,155 13,757
2024-03-31 $35,080 13,757
2023-12-31 $13,660 13,757
2023-09-30 $18,159 13,757
2023-06-30 $27,238 13,757
2023-03-31 $26,413 13,757
2022-12-31 $67,297 32,511
2022-06-30 $83,272 25,781